Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin in AKI-RRT (ALTER-AKI)
NCT04705896Phase 4Recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Nov 2023
- Primary completion
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in acute kidney injury (AKI), sponsored by Ottawa Hospital Research Institute. Started Nov 2023; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04705896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04705896.